ORTEXORTEX News
Tracking SIGI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
SI
Earnings PreviewSIGI

SIGI Heads Into Q3 Print With Bulls Firmly in Charge

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 23 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Selective Insurance Group reports Q3 2026 results today with options positioning unusually skewed toward the upside, while short sellers remain a marginal presence.

The clearest signal heading into the print is in options. The put/call ratio has dropped to 0.11, well below its 20-day average of 0.14 and close to the lowest reading of the past year. Traders are paying far more for calls than puts, reflecting an unusually bullish lean rather than the defensive hedging that typically appears before a major release. The stock has backed that up with price action: up 5.1% on the week and 4.5% over the past month, closing Wednesday at $91.74. Peers have broadly moved in the same direction, with CINF adding 4.2% on the week and HIG up 2.9%, but SIGI has outpaced most of the group. Short interest, at 3.1% of the free float, is a modest position. Borrowing costs have fallen sharply, down 35% over the past week to just 0.36%, and availability in the lending market is extremely loose, leaving no meaningful squeeze pressure in either direction.

The bull and bear debate centres on whether SIGI's underwriting trajectory has genuinely turned. Bulls point to improving results in personal auto driven by New Jersey, a conservative reserve approach in workers' compensation, and a valuation that remains undemanding: the stock trades at a trailing P/E near 10.6x and a price-to-book of 1.4x, both of which have drifted higher over the past month as the shares have recovered. RBC Capital carries the most optimistic published target at $115, well above the current price. Bears are less convinced. The loss ratio climbed 580 basis points in accident year 2025 despite strong premium pricing, raising questions about reserve adequacy in commercial liability lines. BMO Capital downgraded to Market Perform after the prior quarter, and Morgan Stanley keeps an Underweight with an $80 target. The consensus sits at a mean target of $100, implying modest upside from current levels, with analyst sentiment divided rather than aligned.

One data point worth noting from ORTEX's alternative data layer: Wikipedia page views for SIGI carried a z-score of 6.6 as of October 19, indicating a sharp spike in retail attention relative to the company's own recent history. This is a measure of interest, not a revenue indicator, but the timing, four days before a scheduled print, suggests the earnings event itself is drawing in a new wave of retail observers.

The prior quarter's result produced a 2.6% one-day gain. Before that, in July 2026, the stock fell 5.1% on the day and a further 3.1% over the following week. Today's print will test whether the improvements in personal lines and reserve management are sufficient to justify the recent re-rating, or whether commercial liability concerns resurface to reprice the stock back toward where bears have been sitting.

Stocks in this article

See the live data behind this article on ORTEX.

Open SIGI on ORTEX →

How this article was generated

Generated
23 Oct 2026, 04:15
Data as of
23 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.